INS and Hypoglycemia: The association between lower C-peptide levels and CVD was significant after adjustment for clinical and demographic risk factors, baseline insulin and sulphonylureas use, and after adjustment for severe hypoglycemia or visit-to-visit glucose CV (Fig. 1e).